UnitedHealth Previews 41% Q3 EPS Growth Ahead of October 13 Reporting Date
Question
UnitedHealth Previews 41% Q3 EPS Growth Ahead of October 13 Reporting Date
Direct answer
UnitedHealth Group has lagged the broader market over the past month, falling 4.35% into its scheduled Q3 print on October 13. The upcoming results present a key test of operational efficiency, as EPS is projected to expand 41.1% year-over-year to $4.12 while top-line revenue contracts 1.57% to $111.38 billion. Traders are scrutinizing medical loss ratios (MLR) and Medicare Advantage utilization trends to assess whether the guided margin expansion is sustainable heading into 2027 benefit plan adjustments.
- Original publisher
- Market Ontology
- Evidence through
- 2026-10-09
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-21
Cite as: Market Ontology, “UnitedHealth Previews 41% Q3 EPS Growth Ahead of October 13 Reporting Date”, revision 1, evidence through 2026-10-09. https://marketontology.com/market-events/2026-10-09/unitedhealth-previews-41-q3-eps-growth-ahead-of-october-13-reporting-date-bbc446
How this development reaches the affected companies
| Asset | Exposure and channel | Direction | Evidence |
|---|---|---|---|
| UNH | medical loss ratio realization and Q3 EPS delivery against $4.12 target | Mixed1-5d | Source specifies October 13 earnings date, $4.12 EPS expectation, and $111.38B revenue estimate. |
| XLV | healthcare sector weight and managed care subsector sentiment | Mixed1-5d | UNH represents a leading constituent within standard healthcare ETF benchmarks. |
Does this development affect your holdings?
Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| UNH | Mixed | 379.30 2026-10-09 | -0.21% | +5.83% | Pending |
| XLV | Mixed | 170.81 2026-10-09 | +0.69% | +3.45% | Pending |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related
- 2026-10-18UnitedHealth reiterates 13% to 16% growth target on 30% prior auth dropUNH XLV+1.36%
- 2026-10-18UnitedHealth Reaffirms 13% to 16% Target as Q3 Prior Authorizations Fall 30%UNH XLV+1.36%
- 2026-10-18UnitedHealth Reaffirms 13% to 16% Target as Q3 Prior Authorizations Fall 30%UNH XLV+1.36%
- 2026-10-18UnitedHealth reiterates 13% to 16% growth target on 30% prior auth dropUNH XLV+1.36%
- 2026-10-18UnitedHealth reiterates 13-16% growth as AI cuts prior authorizations by 30%UNH XLV+1.36%
- 2026-10-16UnitedHealth, J&J, and BWXT raise FY26 outlooks after solid quarterly earningsBWXT UNH+1.36%
- 2026-10-16BWXT, Johnson & Johnson, and UnitedHealth Raise FY26 OutlooksBWXT JNJ UNH+1.36%
- 2026-10-16UnitedHealth, J&J, and BWXT raise FY26 outlooks after solid quarterly earningsBWXT UNH+1.36%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.